Dr.Shibashis Das, D18765, Dr. Nanda Ashok Kumar
objective:study to evaluate the need of an IOP lowering topical agent after Nd-YAG laser capsulotomy method:50 patients with mild to moderate posterior capsular opacification were randomized into two groups,one group was prescribed brimonidine(0.15%) at the end of the procedure with loteprednol(0.5%) in tapering doses.the other group was prescribed only loteprednol in tapering doses.IOP was measured using applanation tonometer just before the procedure,on day7,14 subsequently.any patient with known history of glaucoma or ocular hypertension or steroid responder were excluded.patients with history of complicated cataract surgery were also excluded. laser was fired with attenuator set at 1(1mj),6-8 shots in a cross hair fashion.
Result:immediate day 1 showed a mean increase of ~4.5(2.0-7.0 mm hg) in the study group and 2.8(1-4 mm hg) in control group.normal levels on day 7,14 in both groups.
conclusion:iop lowering agents are not required in YAG capsulotomy if cases are properly selected